pyridostigmine
CAS No. 155-97-5
pyridostigmine ( Pyridostigminum,Regonol,Mestinon-SR )
产品货号. M22264 CAS No. 155-97-5
Pyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1604 | 有现货 |
|
5MG | ¥2414 | 有现货 |
|
10MG | ¥3669 | 有现货 |
|
25MG | ¥6051 | 有现货 |
|
50MG | ¥8505 | 有现货 |
|
100MG | ¥11502 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称pyridostigmine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Pyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
-
产品描述Pyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy.
-
同义词Pyridostigminum,Regonol,Mestinon-SR
-
通路Others
-
靶点Other Targets
-
受体acetylcholinesterase
-
研究领域——
-
适应症——
化学信息
-
CAS Number155-97-5
-
分子量261.12
-
分子式C9H13BrN2O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ahuja N K , Mische L , Clarke J O , et al. Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis[J]. Semin Arthritis Rheum, 2018:S0049017217305498.
产品手册
关联产品
-
3-Epidehydrotumulosi...
3-Epidehydrotumulosic acid has inhibitory activity against AAPH-induced lysis of red blood cells.
-
Oxyphyllol B
The rhizoma of Bupleurum longibrachiatum Turcz.
-
DL-α-Hydroxyglutaric...
DL-α-Hydroxyglutaric acid disodium salt is an α -hydroxyacid formed from the hydrolysis of (R) -5-oxy-2-tetrahydrofuran carboxylic acid, which is overproduced in human neurometabolic disease D-α -hydroxyglutaric uria. ?